116 related articles for article (PubMed ID: 20732443)
1. Activin A induces SLC5A8 expression through the Smad3 signaling pathway in human colon cancer RKO cells.
Zhang Y; Bao YL; Yang MT; Wu Y; Yu CL; Huang YX; Sun Y; Zheng LH; Li YX
Int J Biochem Cell Biol; 2010 Dec; 42(12):1964-72. PubMed ID: 20732443
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
[TBL] [Abstract][Full Text] [Related]
3. Cloning of Smad2, Smad3, Smad4, and Smad7 from the goldfish pituitary and evidence for their involvement in activin regulation of goldfish FSHbeta promoter activity.
Lau MT; Ge W
Gen Comp Endocrinol; 2005 Mar; 141(1):22-38. PubMed ID: 15707600
[TBL] [Abstract][Full Text] [Related]
4. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.
Li H; Myeroff L; Smiraglia D; Romero MF; Pretlow TP; Kasturi L; Lutterbaugh J; Rerko RM; Casey G; Issa JP; Willis J; Willson JK; Plass C; Markowitz SD
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8412-7. PubMed ID: 12829793
[TBL] [Abstract][Full Text] [Related]
5. Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.
Jung BH; Beck SE; Cabral J; Chau E; Cabrera BL; Fiorino A; Smith EJ; Bocanegra M; Carethers JM
Gastroenterology; 2007 Feb; 132(2):633-44. PubMed ID: 17258738
[TBL] [Abstract][Full Text] [Related]
6. Regulation of FSHβ induction in LβT2 cells by BMP2 and an Activin A/BMP2 chimera, AB215.
Jung JW; Ahn C; Shim SY; Gray PC; Kwiatkowski W; Choe S
J Endocrinol; 2014 Oct; 223(1):35-45. PubMed ID: 25100748
[TBL] [Abstract][Full Text] [Related]
7. Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer.
Park JY; Helm JF; Zheng W; Ly QP; Hodul PJ; Centeno BA; Malafa MP
Pancreas; 2008 May; 36(4):e32-9. PubMed ID: 18437076
[TBL] [Abstract][Full Text] [Related]
8. A high concentration of genistein down-regulates activin A, Smad3 and other TGF-β pathway genes in human uterine leiomyoma cells.
Di X; Andrews DM; Tucker CJ; Yu L; Moore AB; Zheng X; Castro L; Hermon T; Xiao H; Dixon D
Exp Mol Med; 2012 Apr; 44(4):281-92. PubMed ID: 22228119
[TBL] [Abstract][Full Text] [Related]
9. Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor.
Park JY; Zheng W; Kim D; Cheng JQ; Kumar N; Ahmad N; Pow-Sang J
Cancer Detect Prev; 2007; 31(5):359-65. PubMed ID: 18037591
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of the human SLC5A8 gene promoter.
Zhang Y; Bao YL; Wu Y; Yu CL; Sun Y; Li YX
Cancer Genet Cytogenet; 2010 Jan; 196(2):124-32. PubMed ID: 20082847
[TBL] [Abstract][Full Text] [Related]
11. Activin A induces neuronal differentiation and survival via ALK4 in a SMAD-independent manner in a subpopulation of human neuroblastomas.
Suzuki K; Kobayashi T; Funatsu O; Morita A; Ikekita M
Biochem Biophys Res Commun; 2010 Apr; 394(3):639-45. PubMed ID: 20226172
[TBL] [Abstract][Full Text] [Related]
12. Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells.
Burdette JE; Jeruss JS; Kurley SJ; Lee EJ; Woodruff TK
Cancer Res; 2005 Sep; 65(17):7968-75. PubMed ID: 16140969
[TBL] [Abstract][Full Text] [Related]
13. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.
Hong C; Maunakea A; Jun P; Bollen AW; Hodgson JG; Goldenberg DD; Weiss WA; Costello JF
Cancer Res; 2005 May; 65(9):3617-23. PubMed ID: 15867356
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
You L; Kruse FE
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
[TBL] [Abstract][Full Text] [Related]
15. Smad3 and Pitx2 cooperate in stimulation of FSHbeta gene transcription.
Suszko MI; Antenos M; Balkin DM; Woodruff TK
Mol Cell Endocrinol; 2008 Jan; 281(1-2):27-36. PubMed ID: 18022758
[TBL] [Abstract][Full Text] [Related]
16. Activin A, B and AB decrease progesterone production by down-regulating StAR in human granulosa cells.
Chang HM; Cheng JC; Huang HF; Shi FT; Leung PC
Mol Cell Endocrinol; 2015 Sep; 412():290-301. PubMed ID: 26001835
[TBL] [Abstract][Full Text] [Related]
17. Activin A stimulates mouse macrophages to express APRIL via the Smad3 and ERK/CREB pathways.
Lee HJ; Seo GY; Kim JH; Lee MR; Kim PH
Immunol Lett; 2011 Oct; 140(1-2):92-6. PubMed ID: 21784102
[TBL] [Abstract][Full Text] [Related]
18. Activin inhibits the human Pit-1 gene promoter through the p38 kinase pathway in a Smad-independent manner.
de Guise C; Lacerte A; Rafiei S; Reynaud R; Roy M; Brue T; Lebrun JJ
Endocrinology; 2006 Sep; 147(9):4351-62. PubMed ID: 16740974
[TBL] [Abstract][Full Text] [Related]
19. SMAD3 and EGR1 physically and functionally interact in promoter-specific fashion.
Fortin J; Bernard DJ
Cell Signal; 2010 Jun; 22(6):936-43. PubMed ID: 20149866
[TBL] [Abstract][Full Text] [Related]
20. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
